C

China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570

Watchlist Manager
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
Watchlist
Price: 2.29 HKD 0.44% Market Closed
Market Cap: 11.5B HKD
Have any thoughts about
China Traditional Chinese Medicine Holdings Co Ltd?
Write Note

China Traditional Chinese Medicine Holdings Co Ltd
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

China Traditional Chinese Medicine Holdings Co Ltd
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
C
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
Total Receivables
ÂĄ10.2B
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
25%
G
Grand Pharmaceutical Group Ltd
HKEX:512
Total Receivables
HK$4.6B
CAGR 3-Years
25%
CAGR 5-Years
20%
CAGR 10-Years
16%
U
United Laboratories International Holdings Ltd
HKEX:3933
Total Receivables
ÂĄ5.4B
CAGR 3-Years
16%
CAGR 5-Years
15%
CAGR 10-Years
10%
Sino Biopharmaceutical Ltd
HKEX:1177
Total Receivables
ÂĄ7.4B
CAGR 3-Years
12%
CAGR 5-Years
16%
CAGR 10-Years
16%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Total Receivables
HK$85.6B
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Total Receivables
$192.3m
CAGR 3-Years
19%
CAGR 5-Years
35%
CAGR 10-Years
22%
No Stocks Found

China Traditional Chinese Medicine Holdings Co Ltd
Glance View

Market Cap
11.5B HKD
Industry
Pharmaceuticals

China Traditional Chinese Medicine Holdings Co Ltd sits at the crossroads of ancient wisdom and modern commerce. Rooted deeply in the rich heritage of Traditional Chinese Medicine (TCM), this company skillfully crafts a range of products that cater to both domestic and international markets. At the core of its operations is the cultivation and processing of Chinese medicinal herbs, which are transformed into a wide portfolio of products, including ready-to-use TCM formula granules, patented medicines, and healthcare products. By leveraging its extensive network of cultivation bases, the company ensures the authenticity and quality of its raw materials, an essential component in a sector where the efficacy of products is deeply entwined with their origins. The company’s business model thrives on vertical integration, which allows it to exercise control over the entire supply chain—from the sourcing of raw materials to the manufacturing and distribution processes. Through this multifaceted approach, China Traditional Chinese Medicine Holdings Co Ltd maximizes its profit margins while maintaining stringent quality standards, crucial in a market where consumer trust is paramount. The firm's robust distribution network spans pharmacies, hospitals, and retail outlets, supplemented by a growing e-commerce presence. As healthcare trends increasingly lean towards natural and holistic remedies around the globe, the company finds itself well-positioned to not only cater to traditional markets but also to explore new opportunities in alternative medicine sectors worldwide.

Intrinsic Value
4.12 HKD
Undervaluation 44%
Intrinsic Value
Price
C

See Also

What is China Traditional Chinese Medicine Holdings Co Ltd's Total Receivables?
Total Receivables
10.2B CNY

Based on the financial report for Jun 30, 2024, China Traditional Chinese Medicine Holdings Co Ltd's Total Receivables amounts to 10.2B CNY.

What is China Traditional Chinese Medicine Holdings Co Ltd's Total Receivables growth rate?
Total Receivables CAGR 10Y
25%

Over the last year, the Total Receivables growth was 3%. The average annual Total Receivables growth rates for China Traditional Chinese Medicine Holdings Co Ltd have been 14% over the past three years , 13% over the past five years , and 25% over the past ten years .

Back to Top